CARDIUM THERAPEUTICS INC NEW
CXM
CXM was delisted on the 23rd of January, 2014.
0 hedge funds and large institutions have $0 invested in CARDIUM THERAPEUTICS INC NEW in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.
100% less funds holding
Funds holding: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $77K → $0 (-$77K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$29K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$21K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$12K |
| 5 |
Canada Life
Winnipeg,
Manitoba, Canada
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| – | -$29K | -35,100 | Closed |
|
|
2
Creative Planning
Overland Park,
Kansas
| – | -$21K | -25,512 | Closed |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| – | -$13K | -15,324 | Closed |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| – | -$12K | -14,568 | Closed |
|
|
VIA
5
Vantage Investment Advisors
State College,
Pennsylvania
| – | -$1K | -1,350 | Closed |
|
|
6
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$1K | -730 | Closed |
|
CXM Hedge Fund Activity: Q1 2014 in Review
0 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in CARDIUM THERAPEUTICS INC NEW (CXM) for Q1 2014, worth a combined $0 — down 100% from $77K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CXM and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, exiting entirely with an estimated $29K sold.
- 0 institutional investors held CARDIUM THERAPEUTICS INC NEW (CXM) as of Q1 2014, down from 8 in Q4 2013.
- Funds reported $0 of CARDIUM THERAPEUTICS INC NEW stock for Q1 2014, down 100% quarter-over-quarter.
- 0 funds opened new CARDIUM THERAPEUTICS INC NEW positions in Q1 2014 and 8 closed out, a net change of -8 holders.
- The largest CARDIUM THERAPEUTICS INC NEW seller in Q1 2014 was Renaissance Technologies, an estimated $29K sold.
Based on aggregated 13F filings for Q1 2014.